CMS certification 010087
USA Health University Hospital
2451 Fillingim Street, Mobile, AL 36617
USA Health University Hospital has a CMS overall rating of 2 out of 5 stars. 70% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 19 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 2. Emergency patients spend a median of 3 h 31 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,169 completed surveys, 16% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as medium; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | AL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 385 visits sampled · US median for EDs of the same volume: 2 h 45 min | 3 h 31 min | 2 h 29 min | 2 h 42 min |
| Left before being seen Lower is better · 34,917 patients | 2% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 376 patients | 65% | 64% | 65% |
How USA Health University Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| USA Health University HospitalThis hospital | 2/5 | 70% | 3 h 31 min | 2 better 2 worse |
| Springhill Medical CenterSame city | 3/5 | 73% | 2 h 27 min | 1 better 2 worse |
| USA Health HCA Providence Hospital, LLCSame city | 3/5 | 61% | 3 h 32 min | 2 better 2 worse |
| Mobile Infirmary Medical CenterSame city | 2/5 | 64% | 3 h 5 min | 3 better 5 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Mobile.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,744 cases | Too few cases | 4.6% | 3.9% |
| Heart failure 45 cases | Too few cases | 11.5% | 11.1% |
| Pneumonia 45 cases | Too few cases | 17% | 15.2% |
| Stroke 422 cases | Too few cases | 14% | 11.9% |
3 more measures had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.33 likely 0.99 – 1.66 | 1 |
| Deaths after a serious but treatable surgical complication 80 cases | No different | 212.29 per 1,000 likely 164.4 per 1,000 – 260.18 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 2,431 cases | No different | 0.43 per 1,000 likely 0 per 1,000 – 1.19 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 2,983 cases | No different | 0.24 per 1,000 likely 0.02 per 1,000 – 0.46 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 2,989 cases | No different | 0.32 per 1,000 likely 0.11 per 1,000 – 0.52 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 914 cases | No different | 2.22 per 1,000 likely 0.73 per 1,000 – 3.71 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 399 cases | No different | 2.68 per 1,000 likely 1.06 per 1,000 – 4.29 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 421 cases | No different | 16 per 1,000 likely 9.2 per 1,000 – 22.8 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 913 cases | No different | 3.79 per 1,000 likely 1.71 per 1,000 – 5.87 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 389 cases | Worse | 9.14 per 1,000 likely 5.75 per 1,000 – 12.54 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 277 cases | No different | 2.52 per 1,000 likely 1.07 per 1,000 – 3.97 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 835 cases | No different | 1.17 per 1,000 likely 0.25 per 1,000 – 2.09 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 1.03 likely 0.65 – 1.56 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.3 likely 0.13 – 0.6 | 1 |
| Surgical site infections after colon surgery | No different | 0.47 likely 0.12 – 1.29 | 1 |
| MRSA bloodstream infections | Worse | 2.19 likely 1.19 – 3.72 | 1 |
| C. diff intestinal infections | Better | 0.47 likely 0.31 – 0.69 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 75 cases | Too few cases | 13.8% | 14.4% |
| Readmitted after heart failure 138 cases | Too few cases | 19% | 21.3% |
| Readmitted after pneumonia 165 cases | Too few cases | 16.3% | 17.3% |
| Readmitted after COPD 77 cases | Too few cases | 19.8% | 20% |
| Days back in hospital after heart failure 59 cases | Too few cases | 73.1 days per 100 | — |
| Days back in hospital after pneumonia 58 cases | Too few cases | -24.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 368 cases | No different | 13.9 per 1,000 likely 10.5 per 1,000 – 18.6 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 128 cases | No different | 10 per 100 likely 7.3 per 100 – 13.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 128 cases | No different | 4.6 per 100 likely 3.1 per 100 – 6.5 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 162 cases | No different | 0.8 likely 0.6 – 1.2 | — |
4 more measures had too few cases here to report.
Clinicians registered at this address
141 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 13 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 23 |
| Internal Medicine | 19 |
| Diagnostic Radiology | 11 |
| Family | 9 |
| Anatomic Pathology & Clinical Pathology | 8 |
| Anesthesiology | 6 |
| Cardiovascular Disease | 5 |
| Nephrology | 5 |
| Neurology | 5 |
| Acute Care | 4 |
| Nurse Practitioner | 4 |
| Pharmacist | 4 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $406,786
- 2020 $983,667
- 2021 $515,640
- 2022 $348,669
- 2023 $718,310
- 2024 $822,675
- 2025 $854,832
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $59,312 | 47 |
| Speaking, teaching and other services | $29,853 | 2 |
| Space rental and facility fees | $5,000 | 1 |
| Charitable contributions | $4,500 | 2 |
| Debt forgiveness | $1,654 | 4 |
| Food and beverage | $103 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $369,251 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $111,938 | 94 |
| Merck Sharp & Dohme LLC | $88,722 | 6 |
| Eli Lilly and Company | $68,031 | 4 |
| Smith+Nephew, Inc. | $65,000 | 3 |
| Intuitive Surgical, INC. | $52,395 | 9 |
| AstraZeneca Pharmaceuticals LP | $36,268 | 1 |
| ModernaTX, Inc. | $29,853 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING CC-92480 (BMS-986348), CARFILZOMIB AND DEXAMETHASONE (480Kd) VERSUS CARFILZ… E.R. Squibb & Sons, L.L.C. | $369,251 |
| A PHASE 2, DOUBLE-BLIND, 12 WEEK, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF DAILY ORAL ADMINISTRATION OF DEXLANSOPRAZOLE DELAYED-RE… Takeda Pharmaceuticals U.S.A., Inc. · NCT02616302 | $82,188 |
| STUDY OF LOXO-305 VERSUS INVESTIGATOR'S CHOICE (IDELAR OR BR) IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTI… Eli Lilly and Company · NCT04666038 | $68,031 |
| SERENA 4 A Randomised Multicentre Double Blind Phase 3 Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the … AstraZeneca Pharmaceuticals LP | $36,268 |
| A PHASE 2, DOUBLE BLIND, UP TO 40 WEEK, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF DAILY ORAL ADMINISTRATION OF DEXLANSOPRAZOLE DELA… Takeda Pharmaceuticals U.S.A., Inc. · NCT02615184 | $29,750 |
| A Phase 3 Randomized, Open-Label, Study of Pembrolizumab MK-3475 Plus Lenvatinib E7080,MK-7902 Versus Chemotherapy for First-line Treatment of Advanc… Merck Sharp & Dohme LLC | $24,704 |
| A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for … Merck Sharp & Dohme LLC | $22,994 |
| A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizu… Merck Sharp & Dohme LLC | $22,151 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about USA Health University Hospital
Is USA Health University Hospital a good hospital?
USA Health University Hospital has a CMS overall rating of 2 out of 5 stars. Of the 19 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend USA Health University Hospital?
70% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,169 completed HCAHPS surveys.
How long is the wait in the USA Health University Hospital emergency room?
Emergency patients spend a median of 3 h 31 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with medium patient volume, like this one, the median is 2 h 45 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does USA Health University Hospital receive money from drug and device companies?
Drug and device makers reported $854,832 in payments to USA Health University Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.